| [1] |
Yang SH, Dou KF, Song WJ. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010, 362(25):2425-2426.
|
| [2] |
刘颖，肖平，陈焕伟．胰岛移植治疗1型糖尿病的现状和未来[J]. 器官移植，2019, 10(1):91-93.
|
| [3] |
Livingstone SJ, Levin D, Looker HC, et al. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010[J]. JAMA, 2015, 313(1):37-44.
|
| [4] |
Brennan DC, Kopetskie HA, Sayre PH, et al. Long-term follow-up of the Edmonton Protocol of islet transplantation in the United States[J]. Am J Transplant, 2016, 16(2):509-517.
|
| [5] |
姚豫桐，魏玲玲，杨卯竹，等．同种异体胰岛移植治疗1型糖尿病10例及随访观察3年的临床研究[J]．中华器官移植杂志，2016, 37(2):90-94.
|
| [6] |
NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee, NIH CIT Consortium. Purified human pancreatic islet: qualitative and quantitative assessment of islets using dithizone (DTZ): standard operating procedure of the NIH clinical islet transplantation consortium[J]. CellR4 Repair Replace Regen Reprogram, 2015, 3(1):e1369.
|
| [7] |
Street CN, Lakey JR, Shapiro AM, et al. Islet graft assessment in the Edmonton Protocol: implications for predicting long-term clinical outcome[J]. Diabetes, 2004, 53(12):3107-3114.
|
| [8] |
Thompson DM, Meloche M, Ao Z, et al. Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy[J]. Transplantation, 2011, 91(3):373-378.
|
| [9] |
Shapiro AM. State of the art of clinical islet transplantation and novel protocols of immunosuppression[J]. Curr Diab Rep, 2011, 11(5):345-354.
|
| [10] |
Anazawa T, Okajima H, Masui T, et al. Current state and future evolution of pancreatic islet transplantation[J]. Ann Gastroenterol Surg, 2018, 3(1):34-42.
|
| [11] |
Chang CA, Lawrence MC, Naziruddin B. Current issues in allogeneic islet transplantation[J]. Curr Opin Organ Transplant, 2017, 22(5):437-443.
|
| [12] |
Bottino R, Knoll MF, Knoll CA, et al. The future of islet transplantation is now[J]. Front Med, 2018(5):202.
|
| [13] |
Girman P, Saudek F. The IKEM pancreas and islet transplant program as part of healthcare for type 1 diabetes patients: retrospective analysis of outcome from 1983 to 2010[J]. Rev Diabet Stud, 2011, 8(1):35-43.
|
| [14] |
Gürol AO, Yıllar G, Kurşun AO, et al. A modified automated method for isolation of viable pancreatic islets in laboratory animals[J]. Transplant Proc, 2004, 36(5):1526-1527.
|
| [15] |
Shapiro AM, Pokrywczynska M, Ricordi C. Clinical pancreatic islet transplantation[J]. Nat Rev Endocrinol, 2017, 13(5):268-277.
|
| [16] |
Li N, Zhang Y, Liu Y, et al. Improved islet purity by the hypertonic-hypotonic method[J]. Int J Artif Organs, 2014, 37(6):477-485.
|
| [17] |
Ricordi C, Goldstein JS, Balamurugan AN, et al. National institutes of health-sponsored clinical islet transplantation consortium phase 3 trial: manufacture of a complex cellular product at eight processing facilities[J]. Diabetes, 2016, 65(11):3418-3428.
|
| [18] |
Foster ED, Bridges ND, Feurer ID, et al. Improved health-related quality of life in a phase 3 islet transplantation trial in type 1 diabetes complicated by severe hypoglycemia[J]. Diabetes Care, 2018, 41(5): 1001-1008.
|
| [19] |
Holmes-Walker DJ, Gunton JE, Hawthorne W, et al. Islet transplantation provides superior glycemic control with less hypoglycemia compared to continuous subcutaneous insulin infusion or multiple daily insulin injections[J]. Transplantation, 2017, 101(6):1268-1275.
|
| [20] |
Choudhary P, Rickels MR, Senior PA, et al. Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia[J]. Diabetes Care, 2015, 38(6): 1016-1029.
|